SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-001878
Filing Date
2024-01-05
Accepted
2024-01-05 17:01:27
Documents
12
Period of Report
2024-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm242138d1_8k.htm   iXBRL 8-K 22477
  Complete submission text file 0001104659-24-001878.txt   194709

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20240103.xsd EX-101.SCH 3027
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20240103_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20240103_pre.xml EX-101.PRE 22367
6 EXTRACTED XBRL INSTANCE DOCUMENT tm242138d1_8k_htm.xml XML 3317
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38128 | Film No.: 24517384
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)